Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuejiao Shirley Guo

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
ACS Chemical Biology|July 11, 2025
Development of Chemical Tools for the Human YEATS DomainXuejiao Shirley Guo, Abdalrahman Khalifa, Karthik Selvam, et al.
Journal of Medicinal Chemistry|November 12, 2024
Prioritization of Eleven-Nineteen-Leukemia Inhibitors as Orally Available Drug Candidates for Acute Myeloid LeukemiaXuejiao Shirley Guo, Sandeep Atla, Satyanarayana Nyalata, et al.
ACS Central Science|April 29, 2024
Leveraging a Phage-Encoded Noncanonical Amino Acid: A Novel Pathway to Potent and Selective Epigenetic Reader Protein InhibitorsPeng-Hsun Chase Chen, Xuejiao Shirley Guo, Hanyuan Eric Zhang, et al.
Nature Communications|February 14, 2026
From nicotine to SARS-CoV-2 antivirals with potent in vivo efficacy and a broad anti-coronavirus spectrumKaustav Khatua, Sandeep Atla, Demonta Coleman, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
ACS Chemical Biology|July 11, 2025
Development of Chemical Tools for the Human YEATS DomainXuejiao Shirley Guo, Abdalrahman Khalifa, Karthik Selvam, et al.
Journal of Medicinal Chemistry|November 12, 2024
Prioritization of Eleven-Nineteen-Leukemia Inhibitors as Orally Available Drug Candidates for Acute Myeloid LeukemiaXuejiao Shirley Guo, Sandeep Atla, Satyanarayana Nyalata, et al.
ACS Central Science|April 29, 2024
Leveraging a Phage-Encoded Noncanonical Amino Acid: A Novel Pathway to Potent and Selective Epigenetic Reader Protein InhibitorsPeng-Hsun Chase Chen, Xuejiao Shirley Guo, Hanyuan Eric Zhang, et al.
Nature Communications|February 14, 2026
From nicotine to SARS-CoV-2 antivirals with potent in vivo efficacy and a broad anti-coronavirus spectrumKaustav Khatua, Sandeep Atla, Demonta Coleman, et al.
Pageof 1